01-01-2023 | SCLC | Case report
Camrelizumab/irinotecan/nedaplatin
Central retinal vein occlusion and myelopoiesis inhibition: case report
Published in: Reactions Weekly | Issue 1/2023
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event